Steffen Uffenorde: Improving Access to Automated Red Cell Exchange in SCD
Steffen Uffenorde, Head of Market Access and Health Economics, Europe and Middle East at Terumo Blood and Cell Technologies; University Lecturer for International HTA, Pricing and Reimbursement, Pharmacoeconomic Evaluation at Hochschule Fresenius, shared a post on LinkedIn about a recent article by Denise Menezes Brunetta et al., published in Blood Global Hematology, adding:
“International expert opinion on challenges and perspectives in sickle cell disease and equitable access to care: place of automated red cell exchanges.
The authors state: ‘… Resolving the financial burden of SCD management by aRBCX for both patients and apheresis centers by improving reimbursement could facilitate SCD management by aRBCX for all patients requiring it.'”
Title: International expert opinion on challenges and perspectives in sickle cell disease and equitable access to care: place of automated red cell exchanges
Authors: Denise Menezes Brunetta, Luciana Carlos, Luany Carvalho, Elena Cela, Mariane de Montalembert, Saliou Diop, Carlos Escobar, Anabela Ferrão, Teresa Ferreira, Laure Joseph, Grace Kiraka, Joseph Sharif, José Manuel Marco Sánchez, Eva Tsouana, Hind AlHumaidan, Abdullah Al Zayed, Hafiz Malhan, Aurora Vassanelli,
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome
-
Sep 8, 2026, 08:39ASH-a-Palooza – Exploring What’s Next in Hematology